Amplia Therapeutics Limited Stock
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1500 AUD | -3.23% |
|
+20.00% | - |
| Market Cap | 79.56M 56.13M 48.61M 45.32M 41.68M 78.68M 5.34B 533M 209M 2.67B 211M 206M 8.84B | P/E 2027 * |
-6.74x | P/E 2028 * | -22.1x |
|---|---|---|---|---|---|
| Enterprise Value | 61.66M 43.5M 37.68M 35.12M 32.3M 60.98M 4.14B 413M 162M 2.07B 163M 160M 6.85B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 5.91x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | -3.23% | ||
| 1 week | +20.00% | ||
| Current month | +15.38% | ||
| 1 month | -3.23% | ||
| 3 months | +11.11% | ||
| 6 months | +25.00% |
| 1 week | 0.12 |  | 0.18 |
| 1 month | 0.12 | | 0.18 |
| Current year | 0.1 | | 0.28 |
| 1 year | 0.1 | | 0.28 |
| 3 years | 0.05 | | 0.42 |
| 5 years | 0.05 | | 0.42 |
| 10 years | 0.04 | | 18.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 05/12/2022 | |
Hamish George
DFI | Director of Finance/CFO | - | 01/10/2021 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 02/09/2015 |
Warwick Tong
CHM | Chairman | - | 25/05/2018 |
Jane Bell
CHM | Chairman | - | 30/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/9/25 | Fiscal year | Chairman | 750,000 | 0.1933% | ||
| 8/9/25 | Free | Founder | 447,000 | 0.1152% | ||
| 8/9/25 | Fiscal year | Director | 535,000 | 0.1379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.23% | +20.00% | -14.29% | +80.72% | 56.13M | |
| +4.35% | +16.60% | +58.11% | +95.21% | 64.9B | |
| +1.79% | +2.06% | +30.79% | +72.36% | 54.05B | |
| +0.91% | -0.83% | -17.01% | -13.43% | 23.16B | |
| +0.27% | -3.98% | -11.28% | +350.30% | 21.46B | |
| +1.87% | +9.47% | +30.87% | -5.63% | 21.25B | |
| +1.04% | +3.80% | +39.00% | -24.68% | 17.94B | |
| +9.88% | +23.61% | +222.87% | +385.49% | 17.03B | |
| +2.99% | +5.51% | +20.89% | +635.51% | 14.99B | |
| +1.25% | +2.48% | +51.36% | +179.72% | 14.25B | |
| Average | +2.13% | +6.45% | +41.13% | +175.56% | 24.91B | |
| Weighted average by Cap. | +2.80% | +5.91% | +44.14% | +142.07% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 9.5M 6.7M 5.8M 5.41M 4.98M 9.4M 637M 63.58M 24.96M 319M 25.17M 24.62M 1.06B |
| Net income | -11.6M -8.18M -7.09M -6.61M -6.08M -11.47M -778M -77.64M -30.47M -389M -30.74M -30.06M -1.29B | -4.1M -2.89M -2.51M -2.34M -2.15M -4.05M -275M -27.44M -10.77M -138M -10.86M -10.62M -456M |
| Net Debt | -17.9M -12.63M -10.94M -10.2M -9.38M -17.7M -1.2B -120M -47.02M -601M -47.43M -46.38M -1.99B | -23.4M -16.51M -14.3M -13.33M -12.26M -23.14M -1.57B -157M -61.47M -785M -62M -60.63M -2.6B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | $0.1500 | -3.23% | 2,756,011 |
| 05/08/26 | $0.1550 | 0.00% | 3,399,314 |
| 04/08/26 | $0.1550 | +14.81% | 14,383,695 |
| 03/08/26 | $0.1350 | +3.85% | 287,833 |
| 31/07/26 | $0.1300 | +4.00% | 454,864 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1550AUD
Average target price
0.4200AUD
Spread / Average Target
+170.97%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
Select your edition
All financial news and data tailored to specific country editions
